Hypermarcas SA : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Analysis
Summary
ICD Research's Hypermarcas SA : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Analysis contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers & acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.
Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about Hypermarcas SA
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Synopsis
Hypermarcas SA (Hypermarcas) is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax, Neo Química Zero-Cal, Finn and Adocyl. Its products are distributed directly to retailers through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers located in Anapolis and Goiania, Brazil. Hypermarcas is headquartered in Sao Paulo, Brazil.
This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.
The SWOT analysis identifies the company’s strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.
The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.
Reasons To Buy
Quickly enhance your understanding of Hypermarcas SA
Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
Increase business/sales activities by understanding your competitors’ businesses better.
Recognize potential partnerships and suppliers.
Key Highlights
Hypermarcas SA (Hypermarcas) is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax, Neo Química Zero-Cal, Finn and Adocyl. Its products are distributed directly to retailers through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers located in Anapolis and Goiania, Brazil. Hypermarcas is headquartered in Sao Paulo, Brazil.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook